These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6335924)

  • 1. [Comparative study of serum osteocalcin and of the histomorphometric evaluation of iliac biopsy in postmenopausal osteoporosis].
    Delmas PD; Brown JP; Malaval L; Edouard C; Chapuy MC; Meunier PJ
    Rev Rhum Mal Osteoartic; 1984 Nov; 51(10):581-4. PubMed ID: 6335924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone turnover in spinal osteoporosis.
    Pødenphant J; Johansen JS; Thomsen K; Riis BJ; Leth A; Christiansen C
    J Bone Miner Res; 1987 Dec; 2(6):497-503. PubMed ID: 3502682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bone histology in postmenopausal osteoporosis--variations in cellular activity].
    Lozo P; Krpan D; Krvavica A; Vukelić Baturić T; Fistonić I; Kusec V
    Acta Med Croatica; 2004; 58(1):5-11. PubMed ID: 15125387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis.
    Brown JP; Delmas PD; Malaval L; Edouard C; Chapuy MC; Meunier PJ
    Lancet; 1984 May; 1(8386):1091-3. PubMed ID: 6144827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein.
    Delmas PD; Wahner HW; Mann KG; Riggs BL
    J Lab Clin Med; 1983 Oct; 102(4):470-6. PubMed ID: 6604769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients.
    Recker R; Lappe J; Davies KM; Heaney R
    J Bone Miner Res; 2004 Oct; 19(10):1628-33. PubMed ID: 15355557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of bone formation markers osteocalcin and bone-specific alkaline phosphatase in postmenopausal women with osteoporosis.
    Lumachi F; Ermani M; Camozzi V; Tombolan V; Luisetto G
    Ann N Y Acad Sci; 2009 Sep; 1173 Suppl 1():E60-3. PubMed ID: 19751416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alkaline phosphatase isoenzymes and osteocalcin in serum of normal subjects.
    Steinberg KK; Rogers TN
    Ann Clin Lab Sci; 1987; 17(4):241-50. PubMed ID: 3497607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of four biochemical markers of bone metabolism in postmenopausal osteoporosis.
    Majkić-Singh N; Ilić M; Ignjatović S; Aleksandra-Postić-Grujin
    Clin Lab; 2002; 48(7-8):407-13. PubMed ID: 12146575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, biochemical and histological results of a double-blind trial with 1,25-dihydroxyvitamin D3, estradiol and placebo in post-menopausal osteoporosis.
    Caniggia A; Delling G; Nuti R; Lorè F; Vattimo A
    Acta Vitaminol Enzymol; 1984; 6(2):117-28. PubMed ID: 6388277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biochemical markers of bone turnover : clinical usefulness in osteoporosis].
    Garnero P; Delmas PD
    Ann Biol Clin (Paris); 1999; 57(2):137-48. PubMed ID: 10210740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
    Verit FF; Geyikli I; Yazgan P; Celik A
    Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
    Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
    J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Behavior of selected bio-elements in women with osteoporosis].
    Kotkowiak L
    Ann Acad Med Stetin; 1997; 43():225-38. PubMed ID: 9471918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum osteocalcin levels in normal subjects and patients with primary hyperparathyroidism.
    Ljunghall S; Hällgren R; Rastad J
    Exp Clin Endocrinol; 1985 Dec; 86(2):218-22. PubMed ID: 3879222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active bone turnover of the cortico-endosteal envelope in postmenopausal osteoporosis.
    Brown JP; Delmas PD; Arlot M; Meunier PJ
    J Clin Endocrinol Metab; 1987 May; 64(5):954-9. PubMed ID: 3494038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five years of treatment with risedronate and its effects on bone safety in women with postmenopausal osteoporosis.
    Ste-Marie LG; Sod E; Johnson T; Chines A
    Calcif Tissue Int; 2004 Dec; 75(6):469-76. PubMed ID: 15478000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
    Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
    Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Osteocalcin (BGP) values in postmenopausal osteoporosis before and after treatment with calcitonin].
    Rico H; Cabranes JA; Núñez-Torrón M; Higueras JC; Hernández ER
    Med Clin (Barc); 1986 May; 86(19):791-3. PubMed ID: 3488474
    [No Abstract]   [Full Text] [Related]  

  • 20. Common biochemical markers of bone turnover predict future bone loss: a 5-year follow-up study.
    Löfman O; Magnusson P; Toss G; Larsson L
    Clin Chim Acta; 2005 Jun; 356(1-2):67-75. PubMed ID: 15936304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.